2, 2024 /PRNewswire/ -- Innovent Biologics, Inc
The other subtype, PPAR, is primarily expressed in the liver, which is rich in FAs, and can induce the expression of apolipoproteins (APOs), regulating FA catabolism and reducing fatty degeneration (91)
As evidence accrues, we, and others, will monitor what it means for the impact of GLP-1 medications on SMM, but so far we have not seen any compelling clinical data (although new systematic reviews and meta analyses have been proposed ) that GLP-1 medications lead to pathological skeletal muscle mass loss relative to what has been demonstrated and observed in other weight loss interventions
*The packaging may be changed by the manufacturers
For example, protein intakes of up to 1.5 g/kg/day have been suggested for this population 28
GLP-1 agonist use in early pregnancy linked to gestational weight gain and complications #GLP-1 receptor agonist exposure with discontinuation before or during early #pregnancy was associated with greater gestational weight gain and increased risk of preterm delivery, gestational #diabetes, and hypertensive disorders in a cohort mainly composed of women with #obesity
